BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27768637)

  • 1. FUNDUS AUTOFLUORESCENCE FINDINGS IN EARLY CHLOROQUINE MACULOPATHY.
    Bergholz R; Rossel M; Schroeter J; Dutescu RM; Salchow DJ
    Retin Cases Brief Rep; 2018 Spring; 12(2):81-86. PubMed ID: 27768637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U; Renner AB; Tillack H
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence.
    Kellner S; Weinitz S; Kellner U
    Br J Ophthalmol; 2009 Nov; 93(11):1444-7. PubMed ID: 19692385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel optical coherence tomography classification of torpedo maculopathy.
    Wong EN; Fraser-Bell S; Hunyor AP; Chen FK
    Clin Exp Ophthalmol; 2015; 43(4):342-8. PubMed ID: 25266677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular fundus manifestation of two patients following long-term chloroquine therapy: a case report.
    Ma X; Yan L; He L; He D; Lu H
    Diagn Pathol; 2010 Mar; 5():20. PubMed ID: 20346186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.
    Melles RB; Marmor MF
    Ophthalmology; 2015 Jan; 122(1):110-6. PubMed ID: 25182842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foveal cavitation as an optical coherence tomography finding in central cone dysfunction.
    Leng T; Marmor MF; Kellner U; Thompson DA; Renner AB; Moore W; Sowden JC
    Retina; 2012 Jul; 32(7):1411-9. PubMed ID: 22466470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
    Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
    Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
    Rüther K; Foerster J; Berndt S; Schroeter J
    Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically evident chloroquine toxicity undetected by multifocal electroretinogram.
    Burnett HK; Somani R
    Can J Ophthalmol; 2012 Oct; 47(5):e31-3. PubMed ID: 23036562
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment.
    Bertoli F; Šuštar M; Jarc Vidmar M; Perovšek D; Brecelj J; Markelj Š; Jaki Mekjavić P; Šuput D; Tomšič M; Isola M; Battistella C; Lanzetta P; Hawlina M
    Doc Ophthalmol; 2020 Aug; 141(1):1-14. PubMed ID: 31927702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography in a patient with chloroquine-induced maculopathy.
    Korah S; Kuriakose T
    Indian J Ophthalmol; 2008; 56(6):511-3. PubMed ID: 18974527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MULTIMODAL IMAGING DURING THE EVOLUTION OF BLOOD-BRAIN BARRIER DISRUPTION MACULOPATHY.
    Pal BP; Palosaari T; Kivelä T
    Retin Cases Brief Rep; 2019 Winter; 13(1):67-71. PubMed ID: 28098709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOVEAL HYPOPLASIA: DIAGNOSIS USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Sánchez-Vicente JL; Contreras-Díaz M; Llerena-Manzorro L; Rueda T; López-Herrero F; Molina-Socola FE; Muñoz-Morales A; Rodríguez de la Rúa-Franch E
    Retin Cases Brief Rep; 2018 Spring; 12(2):122-126. PubMed ID: 27685500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed progression of bull's eye maculopathy.
    Jain S; Jain NG
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28596207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.